利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

49 条记录 (耗时 0.023 秒)

    Cold Plasma Therapy Device with Enhanced Safety
    42.
    发明申请
    Cold Plasma Therapy Device with Enhanced Safety 有权

    公开(公告)号：US20210220662A1

    公开(公告)日：2021-07-22

    申请号：US17143442

    申请日：2021-01-07

    申请人： Dan Liu ,  Sean Xiaolu Wang

    发明人： Dan Liu ,  Sean Xiaolu Wang

    IPC分类号： A61N1/44 ,  H05H1/46 ,  H05H1/24

    摘要： This invention discloses a cold plasma therapy device with enhanced safety. The plasma therapy device comprises a dielectric barrier made of a material with high dielectric constant (i.e., relative permittivity). Hence the thickness of the dielectric barrier can be increased to produce similar plasma intensity in comparison to a dielectric barrier with a low dielectric constant. The increased thickness enhances the mechanical durability of the dielectric barrier. When the thickness of the dielectric barrier is larger than the maximum discharge gap of the ambient air (or the supplied gas medium) under the voltage applied, no arc discharge will be produced even when there is a crack across the thickness of the dielectric barrier. This minimizes the risk of subject tissue damage from possible electric shocks.

    On-Chip Bus Arbitration Method and Device Thereof
    43.
    发明申请
    On-Chip Bus Arbitration Method and Device Thereof 审中-公开
    片上总线仲裁方法及其设备

    公开(公告)号：US20140189181A1

    公开(公告)日：2014-07-03

    申请号：US14124792

    申请日：2011-10-14

    申请人： Xu Cheng ,  Dan Liu ,  Yi Feng ,  Dong Tong

    发明人： Xu Cheng ,  Dan Liu ,  Yi Feng ,  Dong Tong

    IPC分类号： G06F13/362

    CPC分类号： G06F13/3625 ,  G06F13/374

    摘要： A method and device for on-chip bus arbitration are disclosed. The method includes: dividing devices into a first level, a second level and a third level from high to low; and in each arbitration period, calculating remaining processing time of each real-time transaction, and upgrading a device making a request required to be processed immediately to the first level in the current arbitration period; monitoring bandwidth usage amount of devices of the first level and the second level respectively, and downgrading a device whose bandwidth usage amount exceeds a preset bandwidth threshold value to the third level in the current arbitration period; and in devices making requests for a bus use right, if a device of the highest level is the device of the first level, authorizing the device of the first level; and if it is not the device of the first level, authorizing a device making continuous requests.

    摘要翻译： 公开了用于片上总线仲裁的方法和装置。 该方法包括：将设备分为第一级，第二级和第三级，从高到低; 在每个仲裁期间，计算每个实时交易的剩余处理时间，并且在当前仲裁期间将要求立即处理的请求的设备升级到第一级; 分别监测第一级和第二级的设备的带宽使用量，并且在当前仲裁期间将其带宽使用量超过预设带宽阈值的设备降级到第三级; 并且在要求总线使用权的设备中，如果最高级别的设备是第一级的设备，授权第一级的设备; 并且如果不是第一级的设备，则授权连续请求的设备。

    MOTHERBOARD
    44.
    发明申请
    MOTHERBOARD 审中-公开
    母板

    公开(公告)号：US20130170128A1

    公开(公告)日：2013-07-04

    申请号：US13400770

    申请日：2012-02-21

    申请人： DAN-DAN LIU ,  JIA-QI DONG ,  JI-CHAO LI

    发明人： DAN-DAN LIU ,  JIA-QI DONG ,  JI-CHAO LI

    IPC分类号： G06F1/16

    CPC分类号： G06F1/26

    摘要： A motherboard includes a processor socket, a platform controller hub (PCH), a power circuit, a switch unit, and a memory slot. The PCH is connected to the memory slot and output a bus signal to a serial advanced technology attachment dual in-line memory module (SATA DIMM) when a SATA DIMM is inserted in the memory slot and when the switch unit is in a first state. When a memory module is in the memory slot the power circuit outputs a voltage to the memory module in response to a second state of the switch unit.

    摘要翻译： 主板包括处理器插座，平台控制器集线器（PCH），电源电路，开关单元和存储器插槽。 当SATA DIMM插入内存插槽并且当开关单元处于第一状态时，PCH连接到内存插槽，并将总线信号输出到串行高级技术附件双列直插式内存模块（SATA DIMM）。 当存储器模块在存储器插槽中时，电源电路响应于开关单元的第二状态向存储器模块输出电压。

    THERMOCOUPLE WELDING TEST APPARATUS
    45.
    发明申请
    THERMOCOUPLE WELDING TEST APPARATUS 审中-公开
    热电偶焊接试验装置

    公开(公告)号：US20130163633A1

    公开(公告)日：2013-06-27

    申请号：US13569270

    申请日：2012-08-08

    申请人： DAN LIU ,  SHU-QI WU ,  LI-PING FAN ,  YU-LIN LIU

    发明人： DAN LIU ,  SHU-QI WU ,  LI-PING FAN ,  YU-LIN LIU

    IPC分类号： G01K15/00

    CPC分类号： G01K7/026 ,  G01K15/00 ,  G01K15/007

    摘要： A thermocouple welding test apparatus for testing whether a thermocouple is normally welded includes a first comparison circuit, a second comparison circuit, a switch circuit and an indication circuit. The first comparison circuit receives a first DC voltage from the thermocouple, and compares the first DC voltage with a first reference voltage to output a first control signal. The second comparison circuit receives a second DC voltage from the thermocouple, and compares the second DC voltage with a second reference voltage to output a second control signal. The switch circuit receives the first control signal and the second control signal, and outputs an indication signal accordingly. The indication circuit receives the indication signal, and indicates whether the thermocouple is normally welded accordingly.

    摘要翻译： 用于测试热电偶是否正常焊接的热电偶焊接测试装置包括第一比较电路，第二比较电路，开关电路和指示电路。 第一比较电路从热电偶接收第一直流电压，并将第一直流电压与第一参考电压进行比较，以输出第一控制信号。 第二比较电路从热电偶接收第二直流电压，并将第二直流电压与第二基准电压进行比较，以输出第二控制信号。 开关电路接收第一控制信号和第二控制信号，并相应地输出指示信号。 指示电路接收指示信号，并指示热电偶是否正常焊接。

    Aromatic ring fused triazine derivatives and uses thereof
    46.
    发明授权
    Aromatic ring fused triazine derivatives and uses thereof 有权
    芳香环稠合三嗪衍生物及其用途

    公开(公告)号：US08349835B2

    公开(公告)日：2013-01-08

    申请号：US12867243

    申请日：2009-02-10

    申请人： Linxiang Zhao ,  Jinling Lv ,  Rui Wang ,  Dan Liu ,  Yongkui Jing

    发明人： Linxiang Zhao ,  Jinling Lv ,  Rui Wang ,  Dan Liu ,  Yongkui Jing

    IPC分类号： A61K31/53 ,  C07D253/04

    CPC分类号： C07D253/08 ,  C07D403/12 ,  C07D471/04

    摘要： The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as active ingredient; uses in the preparation of vascular endothelial growth factor receptor tyrosine kinase inhibitors, and uses in the preparation of medicament for the treatment and/or prevention of cancer.

    摘要翻译： 本发明属于制药领域。 本发明涉及式I化合物，包括它们的光学活性形式，药学上可接受的盐或水合物，以及其作为活性成分的药物组合物; 用于制备血管内皮生长因子受体酪氨酸激酶抑制剂，以及用于制备用于治疗和/或预防癌症的药物。

    BLOOD DILUENT AND METHOD OF USE THEREOF
    48.
    发明申请
    BLOOD DILUENT AND METHOD OF USE THEREOF 审中-公开
    血液稀释液及其使用方法

    公开(公告)号：US20090142797A1

    公开(公告)日：2009-06-04

    申请号：US11966713

    申请日：2007-12-28

    申请人： Lina Zhang ,  Dan Liu ,  Wenjuan Xu ,  Mulong Liu

    发明人： Lina Zhang ,  Dan Liu ,  Wenjuan Xu ,  Mulong Liu

    IPC分类号： C07D487/04 ,  C12Q1/00

    CPC分类号： G01N33/5002 ,  G01N1/38 ,  G01N33/5094

    摘要： Blood diluent for use in the analysis of blood components may include at least one purine compound or salt thereof. The blood diluent may also include at least one of alkali metal salt and/or at least one organic buffers and/or inorganic buffer. The blood diluent may be utilized to stabilize blood cells during storage and facilitate the analysis thereof.

    摘要翻译： 用于分析血液成分的血液稀释剂可以包括至少一种嘌呤化合物或其盐。 血液稀释剂还可以包括碱金属盐和/或至少一种有机缓冲剂和/或无机缓冲剂中的至少一种。 血液稀释剂可用于在储存期间稳定血细胞并促进其分析。